FDA Publishes FDARA Mandated Report on Servicing of Medical Devices

By MedTech Intelligence Staff

The report discusses the quality, safety and effectiveness of medical device servicing by OEMs and third parties.

As required by the Food and Drug Administration Reauthorization Act (FDARA), which became law last summer, the FDA has issued a report on the continued quality, safety and effectiveness of medical devices related to servicing. In short, the agency concluded that there isn’t enough evidence to conclude that there is a public health concern regarding servicing, and thus more regulatory requirements are not yet needed in this area.

“The currently available objective evidence is not sufficient to conclude whether or not there is a widespread public health concern related to servicing, including by third party servicers, of medical devices that would justify imposing additional/different, burdensome regulatory requirements at this time,” FDA states in the report. “Rather, the objective evidence indicates that many OEMs and third party entities provide high quality, safe, and effective servicing of medical devices.” The agency also concludes that most comments, complaints and adverse events (including deaths) that put the blame on inadequate servicing were instead related to remanufacturing. FDA also believes the role of third-party firms to service and repair medical devices is “critical”.

While FDA feels establishing more regulatory requirements related to servicing isn’t necessary, it plans to carry out several related actions, including promoting the adoption of quality management principles, clarifying the difference between servicing and manufacturing, strengthening cybersecurity practices related to device servicing, and promoting evidence development to assess the quality, safety and effectiveness of device servicing.

Related Articles

  • Dennis Gucciardo, Hogan Lovells, MedTech Intelligence, Integrated Complaint Management

    Many companies are unsure of how to complete a complaint investigation when the service and repair process is involved.

  • Dr. Christopher Joseph Devine, President, Devine Guidance International

    If your establishment is entering equipment into commerce that is deemed a finished medical device and product servicing is expected during the normal product life-cycle, then compliance with §820.200 is mandated by the QSR. Mandatory means “not optional” in the…

  • Dr. Christopher Joseph Devine, President, Devine Guidance International

    Servicing is a functional requirement, mandated by the Quality System Regulation, and often overlooked by device manufacturers. Though 21 CFR, Part 820.200 is often associated with capital equipment, manufacturers of disposable medical devices still must consider the requirement. It really…

  • FDA

    The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…

About The Author

MedTech Intelligence